PAMELA M WISE OD
Prescription History 1700863321
Optometrist in Mishawaka, IN
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for PAMELA M WISE OD, an active Optometrist specialist practicing in Mishawaka, IN. Our medical registry currently tracks 15 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 593 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 205 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other IN PrescribersVs. IN Avg |
|---|---|---|---|
| Latanoprost | 205 | $25.13 | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 205 Medicare prescriptions for Latanoprost, about 1.7 times the volume of the typical Indiana prescriber of this medication (121). Medicare paid an average of $25.13 per fill, versus $23.86 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 442 30-Day Fills standardized to 30-day supplies 12,964 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 56 | $9.27▼ below IN avg | ▲ More than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 56 Medicare prescriptions for Timolol Maleate, about 5.1 times the volume of the typical Indiana prescriber of this medication (11). Medicare paid an average of $9.27 per fill, versus $561.10 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 145 30-Day Fills standardized to 30-day supplies 4,313 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 55 | $29.16▼ below IN avg | ≈ Typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 55 Medicare prescriptions for Brimonidine Tartrate, about the same volume as the typical Indiana prescriber of this medication (50). Medicare paid an average of $29.16 per fill, versus $40.24 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 106.9 30-Day Fills standardized to 30-day supplies 3,169 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 50 | $392.14▼ below IN avg | ≈ Typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 50 Medicare prescriptions for Lumigan, about the same volume as the typical Indiana prescriber of this medication (52). Medicare paid an average of $392.14 per fill, versus $479.94 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 70 30-Day Fills standardized to 30-day supplies 1,948 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 48 | $32.65▼ below IN avg | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 48 Medicare prescriptions for Prednisolone Acetate, about half the volume of the typical Indiana prescriber of this medication (87). Medicare paid an average of $32.65 per fill, versus $49.69 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 57 30-Day Fills standardized to 30-day supplies 1,314 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 46 | $41.36 | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 46 Medicare prescriptions for Dorzolamide-Timolol, about 70% of the volume of the typical Indiana prescriber of this medication (66). Medicare paid an average of $41.36 per fill, versus $32.44 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 107 30-Day Fills standardized to 30-day supplies 3,211 Days of Medication total across all patients in 2023 | |||
| Ofloxacin | 27 | $11.30▼ below IN avg | ▼ Less than typical |
About Ofloxacin: This medication is used to treat eye infections. Show more ▾ Ofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. In 2023, this provider wrote 27 Medicare prescriptions for Ofloxacin, about half the volume of the typical Indiana prescriber of this medication (55). Medicare paid an average of $11.30 per fill, versus $21.68 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 27 30-Day Fills standardized to 30-day supplies 467 Days of Medication total across all patients in 2023 | |||
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 24 | $12.00▼ below IN avg | ≈ Typical |
About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾ This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2023, this provider wrote 24 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about 80% of the volume of the typical Indiana prescriber of this medication (30). Medicare paid an average of $12.00 per fill, versus $13.98 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 24.7 30-Day Fills standardized to 30-day supplies 440 Days of Medication total across all patients in 2023 | |||
| Brinzolamide | 13 | $304.79▼ below IN avg | ▼ Less than typical |
About Brinzolamide: Brinzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 13 Medicare prescriptions for Brinzolamide, about half the volume of the typical Indiana prescriber of this medication (22). Medicare paid an average of $304.79 per fill, versus $352.04 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 25.2 30-Day Fills standardized to 30-day supplies 755 Days of Medication total across all patients in 2023 | |||
| VyzultaLatanoprostene Bunod | 13 | $461.22 | ▼ Less than typical |
About Vyzulta: Latanoprostene bunod is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by controlling the flow of fluid within the eye to maintain a normal pressure. In 2023, this provider wrote 13 Medicare prescriptions for Vyzulta, about half the volume of the typical Indiana prescriber of this medication (27). Medicare paid an average of $461.22 per fill, versus $440.20 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16.8 30-Day Fills standardized to 30-day supplies 478 Days of Medication total across all patients in 2023 | |||
| ErythromycinErythromycin Base | 12 | $5.40▼ below IN avg | ▼ Less than typical |
About Erythromycin: Erythromycin is used to treat a wide variety of bacterial infections. Show more ▾ It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2023, this provider wrote 12 Medicare prescriptions for Erythromycin, about a third of the volume of the typical Indiana prescriber of this medication (40). Medicare paid an average of $5.40 per fill, versus $26.52 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 12 30-Day Fills standardized to 30-day supplies 232 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 11 | $232.18▼ below IN avg | ▼ Less than typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 11 Medicare prescriptions for Brimonidine Tartrate-Timolol, about half the volume of the typical Indiana prescriber of this medication (20). Medicare paid an average of $232.18 per fill, versus $287.31 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 15.4 30-Day Fills standardized to 30-day supplies 403 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 11 | $43.85 | ▼ Less than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 11 Medicare prescriptions for Dorzolamide Hcl, about a quarter of the volume of the typical Indiana prescriber of this medication (45). Medicare paid an average of $43.85 per fill, versus $30.76 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25.7 30-Day Fills standardized to 30-day supplies 770 Days of Medication total across all patients in 2023 | |||
| RestasisCyclosporine | 11 | $809.67▼ below IN avg | ▼ Less than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 11 Medicare prescriptions for Restasis, about a third of the volume of the typical Indiana prescriber of this medication (33). Medicare paid an average of $809.67 per fill, versus $1,117.13 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
| XiidraLifitegrast | 11 | $997.64▼ below IN avg | ▼ Less than typical |
About Xiidra: This medication is used to treat dry eye disease. In 2023, this provider wrote 11 Medicare prescriptions for Xiidra, about half the volume of the typical Indiana prescriber of this medication (23). Medicare paid an average of $997.64 per fill, versus $1,089.87 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for PAMELA M WISE OD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Mishawaka, IN practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among IN prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
